HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsPricing
Theme
Help Login Register
Market News Stocks News ETF News Crypto News

Axsome Therapeutics, Inc.

Contributing Author

Recent Articles by Axsome Therapeutics, Inc.

May-28
Axsome Therapeutics Presents Data from Three of Its Innovative Neuroscience Programs at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual Meeting AXSM GlobeNewswire
May-27
Axsome Therapeutics Settles SUNOSI (solriamfetol) Patent Litigation with Hetero Labs Ltd. AXSM GlobeNewswire
May-13
Axsome Therapeutics Enters $570 Million Term Loan and Revolving Credit Facility with Blackstone AXSM GlobeNewswire
May-05
Axsome Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update AXSM GlobeNewswire
Affiliate • Advertise • Theme Settings • Contact • Help • Privacy • Do Not Sell My Data
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.

Upgrade your FINVIZ experience

Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.

Learn more about FINVIZ*Elite